An Open-Label, Randomized, Three-Treatment, Three-Way Crossover Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2018
Price : $35 *
At a glance
- Drugs Cilostazol (Primary) ; Cilostazol
- Indications Intermittent claudication
- Focus Pharmacokinetics
- Sponsors Genovate Biotechnology
- 09 Jul 2018 Status changed from active, no longer recruiting to completed.
- 01 May 2018 Planned End Date changed from 1 Oct 2018 to 29 May 2018.
- 01 May 2018 Status changed from recruiting to active, no longer recruiting.